These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14703926)

  • 1. Use of kidneys from hepatitis C seropositive donors shortens waitlist time but does not alter one-yr outcome.
    Woodside KJ; Ishihara K; Theisen JE; Early MG; Covert LG; Hunter GC; Gugliuzza KK; Daller JA
    Clin Transplant; 2003 Oct; 17(5):433-7. PubMed ID: 14703926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors.
    Mandal AK; Kraus ES; Samaniego M; Rai R; Humphreys SL; Ratner LE; Maley WR; Burdick JF
    Clin Transplant; 2000 Aug; 14(4 Pt 2):391-6. PubMed ID: 10946777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.
    Kucirka LM; Peters TG; Segev DL
    Am J Kidney Dis; 2012 Jul; 60(1):112-20. PubMed ID: 22560841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of kidney transplantation from HCV-positive donors.
    Kasprzyk T; Kwiatkowski A; Wszola M; Ostrowski K; Danielewicz R; Domagala P; Malkowski P; Fesolowicz S; Nosek R; Czerwinski J; Trzebicki J; Durlik M; Paczek L; Patrzalek D; Rowinski W; Chmura A
    Transplant Proc; 2007 Nov; 39(9):2701-3. PubMed ID: 18021962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of donor gender on graft survival.
    Zeier M; Döhler B; Opelz G; Ritz E
    J Am Soc Nephrol; 2002 Oct; 13(10):2570-6. PubMed ID: 12239247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of kidneys from HCV-positive donors: a safe strategy?
    Fabrizi F; Bunnapradist S; Lunghi G; Martin P
    J Nephrol; 2003; 16(5):617-25. PubMed ID: 14733406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation.
    Bucci JR; Matsumoto CS; Swanson SJ; Agodoa LY; Holtzmuller KC; Peters TG; Abbott KC
    J Am Soc Nephrol; 2002 Dec; 13(12):2974-82. PubMed ID: 12444217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplantation from hepatitis B surface antigen-positive donors into hepatitis B surface antigen-positive recipients: preliminary findings.
    Veroux M; Puliatti C; Macarone M; Cappello D; Gagliano M; Spataro M; Di Mare M; Giuffrida G; Veroux P
    Transplant Proc; 2005; 37(6):2467-8. PubMed ID: 16182711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of kidney donors with hepatitis B, hepatitis C, or brain tumor: a single-center experience.
    Tatar E; Turan MN; Firat O; Sezer TO; Sozbilen M; Solak I; Toz H; Hoscoskun C
    Transplant Proc; 2012; 44(6):1601-3. PubMed ID: 22841224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors.
    Metselaar HJ; Ploeg RJ; Van Loon AM; Weiland HT; Rothbarth PH; Paul LC; Brand A; Schaafsma R; Hendriks GF; Jeekel J
    Scand J Infect Dis; 1988; 20(2):135-9. PubMed ID: 2840730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts.
    Scalea JR; Barth RN; Munivenkatappa R; Philosophe B; Cooper M; Whitlow V; LaMattina JC
    Transplantation; 2015 Jun; 99(6):1192-6. PubMed ID: 25340605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation from hepatitis C virus-positive donors into hepatitis C virus-positive recipients: a safe way to expand the donor pool?
    Veroux P; Veroux M; Puliatti C; Cappello D; Macarone M; Gagliano M; Fiamingo P; Di Mare M; Spataro M; Ginevra N
    Transplant Proc; 2005; 37(6):2571-3. PubMed ID: 16182747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preemptive kidney transplantation in elderly recipients with kidneys discarded of very old donors: A good alternative.
    Morales E; Gutiérrez E; Hernández A; Rojas-Rivera J; Gonzalez E; Hernández E; Polanco N; Praga M; Andrés A
    Nefrologia; 2015; 35(3):246-55. PubMed ID: 26299167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal transplantation in recipients over the age of 60: the impact of donor age.
    Basar H; Soran A; Shapiro R; Vivas C; Scantlebury VP; Jordan ML; Gritsch HA; McCauley J; Randhawa P; Irish W; Hakala TR; Fung JJ
    Transplantation; 1999 Apr; 67(8):1191-3. PubMed ID: 10232574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double versus single renal allografts from aged donors.
    Andrés A; Morales JM; Herrero JC; Praga M; Morales E; Hernández E; Ortuño T; Rodício JL; Martínez MA; Usera G; Díaz R; Polo G; Aguirre F; Leiva O
    Transplantation; 2000 May; 69(10):2060-6. PubMed ID: 10852597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of Renal Transplant From Deceased Anti-hepatitis C Virus Donors, Poland 1998-2012.
    Pliszczyński J; Jasztal K; Jóźwik A; Kosieradzki M; Danielewicz R; Małkowski P; Czerwiński J
    Transplant Proc; 2018; 50(6):1691-1696. PubMed ID: 30056883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney.
    Shelton BA; Sawinski D; Mehta S; Reed RD; MacLennan PA; Locke JE
    Transpl Infect Dis; 2018 Apr; 20(2):e12829. PubMed ID: 29277956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.